A carregar...

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

The tumor biology targeted therapies have improved outcomes in colorectal cancer (CRC). The epidermal growth factor receptor (EGFR) inhibitors represent one of these successful strategies. EGFR is frequently overexpressed in CRCs and associated with a malignant phenotype. Two EGFR inhibitors have sh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Williams, Kerry J, Lockhart, A Craig
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886332/
https://ncbi.nlm.nih.gov/pubmed/20616903
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!